A crucial factor of regenerative medicine and drug discovery lies in the ability to grow human stem cell collections to sufficient quantities for therapeutic applications. Traditionally, restricted cell presence posed a significant barrier to development in these fields. Consequently, considerable effort has been directed towards improving protocol